NEVIRAPINE vs VITEKTA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. NEVIRAPINE and VITEKTA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	NEVIRAPINE	VITEKTA
Rating	66/100	70/100
Pharmacy pays	~$4.55 /30	—
Type	RX	RX
Active ingredient	NEVIRAPINE	ELVITEGRAVIR
Manufacturer	Mylan	Gilead Sciences Inc
Dosage forms	Suspension, Tablet, Tablet, extended release	Tablet
Drug class	Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor	—
Boxed warning	Boxed warning	None
Treats	Acquired Immunodeficiency Syndrome, Hiv Infections	Hiv Infections

nevirapine vitekta

Rating

66/100

70/100

Pharmacy pays

~$4.55 /30

—

Type

Active ingredient

NEVIRAPINE

ELVITEGRAVIR

Manufacturer

Mylan

Gilead Sciences Inc

Dosage forms

Suspension, Tablet, Tablet, extended release

Tablet

Drug class

Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor

—

Boxed warning

None

Treats

Acquired Immunodeficiency Syndrome, Hiv Infections

Hiv Infections

Frequently asked questions

Which is better-rated, Nevirapine or Vitekta?

By our independent rating, Vitekta scores higher — 3.5 vs 3.3 out of 5 for Nevirapine. Ratings are based on FDA regulatory (recall-safety) data.

What is the difference between Nevirapine and Vitekta?

Nevirapine contains Nevirapine, while Vitekta contains Elvitegravir — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.